Literature DB >> 23235650

Antenatal cardiotocography for fetal assessment.

Rosalie M Grivell1, Zarko Alfirevic, Gillian M L Gyte, Declan Devane.   

Abstract

BACKGROUND: Cardiotocography (CTG) is a continuous recording of the fetal heart rate obtained via an ultrasound transducer placed on the mother's abdomen. CTG is widely used in pregnancy as a method of assessing fetal well-being, predominantly in pregnancies with increased risk of complications.
OBJECTIVES: To assess the effectiveness of antenatal CTG (both traditional and computerised assessments) in improving outcomes for mothers and babies during and after pregnancy. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (9 July 2012) and reference lists of retrieved studies. SELECTION CRITERIA: Randomised and quasi-randomised trials that compared traditional antenatal CTG with no CTG or CTG results concealed; computerised CTG with no CTG or CTG results concealed; and computerised CTG with traditional CTG. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed eligibility, quality and extracted data. MAIN
RESULTS: Six studies (involving 2105 women) are included. Overall, the included studies were not of high quality, and only two had both adequate randomisation sequence generation and allocation concealment. All studies that were able to be included enrolled only women at increased risk of complications.Comparison of traditional CTG versus no CTG showed no significant difference identified in perinatal mortality (risk ratio (RR) 2.05, 95% confidence interval (CI) 0.95 to 4.42, 2.3% versus 1.1%, four studies, N = 1627) or potentially preventable deaths (RR 2.46, 95% CI 0.96 to 6.30, four studies, N = 1627), though the meta-analysis was underpowered to assess this outcome. Similarly, there was no significant difference identified in caesarean sections (RR 1.06, 95% CI 0.88 to 1.28, 19.7% versus 18.5%, three trials, N = 1279) nor in the secondary outcomes that were assessed.There were no eligible studies that compared computerised CTG with no CTG.Comparison of computerised CTG versus traditional CTG showed a significant reduction in perinatal mortality with computerised CTG (RR 0.20, 95% CI 0.04 to 0.88, two studies, 0.9% versus 4.2%, 469 women). However, there was no significant difference identified in potentially preventable deaths (RR 0.23, 95% CI 0.04 to 1.29, two studies, N = 469), though the meta-analysis was underpowered to assess this outcome. There was no significant difference identified in caesarean sections (RR 0.87, 95% CI 0.61 to 1.24, 63% versus 72%, one study, N = 59) or in secondary outcomes. AUTHORS'
CONCLUSIONS: There is no clear evidence that antenatal CTG improves perinatal outcome, but further studies focusing on the use of computerised CTG in specific populations of women with increased risk of complications are warranted.

Entities:  

Mesh:

Year:  2012        PMID: 23235650     DOI: 10.1002/14651858.CD007863.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  11 in total

1.  Rates and indicators of Continuous Electronic fetal monitoring - A study from Saudi Arabia.

Authors:  Zaheera Saadia
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

2.  Changes of the plasma metabolome of newly born piglets subjected to postnatal hypoxia and resuscitation with air.

Authors:  Rønnaug Solberg; Julia Kuligowski; Leonid Pankratov; Javier Escobar; Guillermo Quintás; Isabel Lliso; Ángel Sánchez-Illana; Ola Didrik Saugstad; Máximo Vento
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

3.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

4.  Association Between Fetal Middle Cerebral Artery and Umbilical Artery Doppler Ratio with Fetal Distress in 38-40 Weeks of Gestation.

Authors:  Sara Masihi; Roshan Nikbakht; Mojgan Barati; Mohammad Momen Gharibvand; Azam Jadidi
Journal:  J Obstet Gynaecol India       Date:  2019-07-17

Review 5.  Sepsis and pregnancy: do we know how to treat this situation?

Authors:  Ricardo Luiz Cordioli; Eduardo Cordioli; Romulo Negrini; Eliezer Silva
Journal:  Rev Bras Ter Intensiva       Date:  2013 Oct-Dec

6.  Comparison of diurnal variations, gestational age and gender related differences in fetal heart rate (FHR) parameters between appropriate-for-gestational-age (AGA) and small-for-gestational-age (SGA) fetuses in the home environment.

Authors:  Habiba Kapaya; Richard Jacques; Dilly Anumba
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

7.  What is the "normal" fetal heart rate?

Authors:  Stephanie Pildner von Steinburg; Anne-Laure Boulesteix; Christian Lederer; Stefani Grunow; Sven Schiermeier; Wolfgang Hatzmann; Karl-Theodor M Schneider; Martin Daumer
Journal:  PeerJ       Date:  2013-06-04       Impact factor: 2.984

Review 8.  Antenatal cardiotocography for fetal assessment.

Authors:  Rosalie M Grivell; Zarko Alfirevic; Gillian M L Gyte; Declan Devane
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12

Review 9.  Fetal movements as a predictor of health.

Authors:  Jonathan Lai; Niamh C Nowlan; Ravi Vaidyanathan; Caroline J Shaw; Christoph C Lees
Journal:  Acta Obstet Gynecol Scand       Date:  2016-09       Impact factor: 3.636

10.  Short-Term Effects of Dexamethasone versus Betamethasone on Ultrasonic Measures of Fetal Well-Being: Cohort from a Blinded, Randomized Trial.

Authors:  Amanda Henry; Aditi Mahajan; Caroline A Crowther; Anne Lainchbury; Lynne Roberts; Antonia W Shand; Alec W Welsh
Journal:  Fetal Diagn Ther       Date:  2021-07-28       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.